BASALOG ONE INJECTION PEN

BASALOG One Injection Pen contains insulin glargine, a long-acting insulin analogue used to manage blood sugar levels in people with type 1 and type 2 diabetes mellitus. It provides steady, prolonged insulin release over 24 hours, helping maintain stable glucose levels throughout the day and night. This reduces the risk of sudden blood sugar fluctuations and improves overall glycemic control.

The BASALOG One Pen is designed for convenient, once-daily subcutaneous injection. It is commonly used as basal insulin therapy and may be combined with rapid-acting insulin or oral antidiabetic medicines for comprehensive diabetes management. By maintaining consistent blood sugar control, BASALOG helps reduce the risk of long-term complications such as kidney damage, nerve problems, heart disease, and vision issues.

The injection pen should be used under medical supervision, and dosage depends on blood glucose levels, diet, and individual patient needs. Common side effects may include hypoglycemia (low blood sugar), mild weight gain, or injection site reactions. Regular blood sugar monitoring and proper injection technique are essential for safe and effective treatment. Store in a refrigerator and avoid freezing.

Product Features

• Contains Insulin Glargine (Long-acting insulin)
• Provides 24-hour basal glucose control
• Once-daily convenient injection pen
• Helps manage type 1 and type 2 diabetes
• Supports stable blood sugar levels

How It Helps

• Contains Insulin Glargine (Long-acting insulin)
• Provides 24-hour basal glucose control
• Once-daily convenient injection pen
• Helps manage type 1 and type 2 diabetes
• Supports stable blood sugar levels